Omega Therapeutics, Inc.


1.84 (USD) • At close July 24, 2024
Bedrijfsnaam Omega Therapeutics, Inc.
Symbool OMGA
Munteenheid USD
Prijs 1.84
Beurswaarde 101,485,200
Dividendpercentage 0%
52-weken bereik 1.3 - 6.3
Industrie Biotechnology
Sector Healthcare
CEO Mr. Mahesh Karande

An error occurred while fetching data.

Over Omega Therapeutics, Inc.

Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a,

Vergelijkbare Aandelen

Societal CDMO, Inc. logo

Societal CDMO, Inc.


1.1 USD

Vascular Biogenics Ltd. logo

Vascular Biogenics Ltd.


0.156 USD

INmune Bio, Inc. logo

INmune Bio, Inc.


8.26 USD

Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc.


1.4 USD

Portage Biotech Inc. logo

Portage Biotech Inc.


0.184 USD

FONAR Corporation logo

FONAR Corporation


18.45 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)